Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Feb;20(2):65-71.
doi: 10.1016/j.bjae.2019.11.001. Epub 2020 Jan 8.

Drug reactions with eosinophilia and systemic symptoms

Affiliations
Review

Drug reactions with eosinophilia and systemic symptoms

B Scrace et al. BJA Educ. 2020 Feb.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflicts of interest.

Figures

Fig. 1
Fig. 1
Widespread atypical target lesions in a patient with DRESS syndrome.
Fig. 2
Fig. 2
Widespread atypical target lesions in a patient with DRESS syndrome.

References

    1. Husain Z., Reddy B., Schwartz R. Dress syndrome: Part 1. Clinical perspectives. J Am Acad Dermatol. 2013;68:693. e1–14. - PubMed
    1. Bocquet H., Bagot M., Roujeau J.C. Drug induced pseudolymphoma and drug hypersensitivity syndrome (drug reaction with eosinophilia and systemic symptoms: DRESS) Semin Cutan Med Surg. 1996;15:250–257. - PubMed
    1. Kardaun S.H., Sekula P., Valeyrie-Allanore L. Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study. Br J Dermatol. 2013;169:1071–1080. - PubMed
    1. Tas S., Simonart T. Drug rash with eosinophilia and systemic symptoms (DRESS syndrome) Acta Clin Belg. 1999;54:197–200. - PubMed
    1. Ganeva M., Gancheva T., Lazarova R. Carbamazepine-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: report of four cases and brief review. Int J Dermatol. 2008;47:853–860. - PubMed